You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

immunosuppressive agents

Showing 1 - 25 of 7,055
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immunosuppressants to Postoperative Infection and Death

Recruiting
  • Organ Transplantation
  • +2 more
  • Immunosuppressive Agents
  • Taichung, Taiwan
    Chung Shan Medical University
Nov 6, 2023

Informed preciSion doSIng tO iNdividualise and Optimize

Not yet recruiting
  • Pharmacokinetics
  • +4 more
  • venipuncture
  • (no location specified)
Oct 16, 2023

Rheumatic Diseases Trial in Ciudad Autónoma de Buenos Aires (Immunosuppressive Agents)

Completed
  • Rheumatic Diseases
  • Immunosuppressive Agents
  • Ciudad Autónoma de Buenos Aires, Caba, Argentina
    Sociedad Argentina de Reumatología
Jan 30, 2023

Lupus Nephritis, Remission, Safety Issues Trial in Nanjing (Methylprednisolone Injectable Suspension, Belimumab Injection,

Recruiting
  • Lupus Nephritis
  • +2 more
  • Methylprednisolone Injectable Suspension
  • +2 more
  • Nanjing, Jiangsu, China
    Jiong Zhang
May 8, 2023

Thyroid Associated Ophthalmopathy Trial in Guangzhou (immunosuppressive agent)

Recruiting
  • Thyroid Associated Ophthalmopathy
  • immunosuppressive agent
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center
Nov 7, 2021

/Pharmacodynamic Models in Kidney Transplant Patients

Active, not recruiting
  • Kidney Transplantation
  • Immunosuppressive Agents
    • Chongqing, China
      The Second Affiliated Hospital of Chongqing Medical University
    May 15, 2023

    Glomerulonephritis Rapidly Progressive Trial (ALE.F02, Rituximab, GlucoCorticoid)

    Not yet recruiting
    • Glomerulonephritis Rapidly Progressive
    • ALE.F02
    • +5 more
    • (no location specified)
    Sep 14, 2023

    Anti-HLA Immunization And Immunosuppressive Therapy Management

    Active, not recruiting
    • Kidney Transplantation
    • +3 more
    • management of immunosuppressive therapy
    • Nancy, Lorraine, France
      Central HNF
    Mar 24, 2022

    Hepatitis, Autoimmune, Cholangitis, Liver Cirrhosis, Biliary Trial in Chengdu (Ursodeoxycholic acid combination of

    Recruiting
    • Hepatitis, Autoimmune
    • +3 more
    • Ursodeoxycholic acid combination of immunosuppressive agents
    • Ursodeoxycholic Acid
    • Chengdu, Sichuan, China
      West China Hospital
    Oct 26, 2021

    Ocular Myasthenia Gravis Trial in Xi'an (Symptomatic Treatment, Steroids, Immunosuppressive Agents( azathioprine, tacrolimus,

    Recruiting
    • Ocular Myasthenia Gravis
    • Symptomatic Treatment, Steroids, Immunosuppressive Agents( azathioprine, tacrolimus, Mycophenolate Mofetil)
    • Xi'an, Shaanxi, China
      Tangdu Hospotal
    Aug 16, 2022

    Inflammatory Disease, Disease Crohn, Bowel Disease Trial in Amsterdam (Infliximab subcutaneous, Immunosuppressive Agents)

    Recruiting
    • Inflammatory Disease
    • +2 more
    • Infliximab subcutaneous
    • Immunosuppressive Agents
    • Amsterdam, North Holland, Netherlands
      Amsterdam UMC AMC
    Sep 27, 2023

    Kidney Transplant Rejection Trial (MDR-102, Immunosuppressive Agents)

    Not yet recruiting
    • Kidney Transplant Rejection
    • MDR-102
    • Immunosuppressive Agents
    • (no location specified)
    Apr 4, 2022

    Type 1 Diabetes Trial in Duarte (Allogenic Human Islet Cells, Immunosuppressive Agents, Gastrin 17)

    Recruiting
    • Type 1 Diabetes Mellitus
    • Allogenic Human Islet Cells
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Feb 17, 2022

    Idiopathic Membranous Nephropathy Trial in Beijing (Prednisone, MP and CTX)

    Terminated
    • Idiopathic Membranous Nephropathy
    • Beijing, China
      Beijing Friendship Hospital, Capital Medical University
    Feb 2, 2022

    Kidney; Complications, Allograft, Transplantation Infection Trial in Loma Linda (Immunosuppressive Agents)

    Active, not recruiting
    • Kidney; Complications, Allograft
    • Transplantation Infection
    • Immunosuppressive Agents
    • Loma Linda, California
      Loma Linda University Medical Center, Transplantation Institute
    Apr 28, 2022

    Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)

    Recruiting
    • Leukemia
    • +19 more
    • CYNK-001
    • Denver, Colorado
    • +9 more
    Sep 9, 2022

    Clinical Prognosis and Progression of Myasthenia Gravis Patients

    Recruiting
    • Myasthenia Gravis
    • Symptomatic Treatment, Steroids, Immunosuppressive Agents, Plasma Exchange(PE), Intravenous Immunoglobulin(IVIg)
    • Beijing, Beijing, China
      Xuan Wu Hospital, Capital Medical University
    Aug 19, 2021

    Abdominal Wall Defect Trial in Boston (abdominal wall transplantation, Immunosuppressive Agents)

    Recruiting
    • Abdominal Wall Defect
    • abdominal wall transplantation
    • Immunosuppressive Agents
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Jan 25, 2021

    Liver Transplantation Trial in Taoyuan (Advagraf, Prograf)

    Recruiting
    • Liver Transplantation
    • Taoyuan, Taiwan
      Chang Gung Memorial Hospital
    Jun 4, 2020

    Pneumocystis, Steroids, Immunocompromised Patient Trial in Paris (Methylprednisolone, Placebo)

    Recruiting
    • Pneumocystis
    • +5 more
    • Paris, France
      Medical ICU
    Oct 5, 2020

    De Novo Metabolic Syndrome in Liver Transplant Patients After

    Completed
    • Single Transplant
    • 5 Years of Follow-up After Transplant, in Which an Attempt Was Made to Suspend IS
    • Rome, Italy
      Roberta Angelico
    Mar 29, 2023

    Nephrotic Syndrome in Children Trial in China (Tacrolimus, Mycophenolate Mofetil)

    Active, not recruiting
    • Nephrotic Syndrome in Children
    • Beijing, Beijing, China
    • +11 more
    Jun 29, 2022

    Nephrotic Syndrome in Children Trial in China (Adrenocorticotrophic Hormone, Steroid)

    Recruiting
    • Nephrotic Syndrome in Children
    • Wuhan, Hubei, China
    • +7 more
    Oct 8, 2023

    Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, End Stage Renal Disease Trial in France (Discontinuation (or not

    Recruiting
    • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
    • End Stage Renal Disease
    • Discontinuation (or not initiation) of Immunosuppressive Therapy
    • Maintenance (or initiation) of immunosuppressive treatment: Imurel®, Mabthera®,Cellcept®, Cortancyl®
    • Amiens, France
    • +54 more
    Jan 6, 2023

    Severe Aplastic Anemia Trial in Tianjin (Cyclophosphamide added to standard immunosuppressive therapy with eltrombopag)

    Recruiting
    • Severe Aplastic Anemia
    • Cyclophosphamide added to standard immunosuppressive therapy with eltrombopag
    • Tianjin, Tianjin, China
      Regenerative Medicine Center
    Jul 27, 2023